Author

Weizhen Wu

Regeneron (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Organism:mouse· 1 Approach:statistical model· 1 Research Focus:variant effect prediction· 1

Frequent Co-Authors

Adam E. LockeiD· 1 shared Alan R. ShuldineriD· 1 shared Alexander H. LiiD· 1 shared Anthony MarckettaiD· 1 shared Aris N. EconomidesiD· 1 shared Arunachalam VinayagamiD· 1 shared Bin YeiD· 1 shared Cristopher V. Van HoutiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetic & Genomic Medicine

Adam E. LockeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic inactivation of zinc transporter SLC39A5 improves liver function and hyperglycemia in obesogenic settings

Shek Man Chim, Kristen Howell, John Dronzek, Weizhen Wu, Cristopher V. Van Hout, Manuel A. R. Ferreira, Bin Ye, Alexander H. Li, Susannah D. Brydges, Arunachalam Vinayagam, Anthony Marcketta, Adam E. Locke, Jonas Bovijn, Niek Verweij, Tanima De, , Harikiran Nistala

The paper identifies SLC39A5 as a gene whose loss-of-function variants are associated with reduced type II diabetes risk and improved liver function in metabolic disorders.

eLife · Dec 13, 2024Peer-reviewedGenetic & Genomic Medicine